These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25128329)

  • 1. OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.
    Yue PJ; He L; Qiu SW; Li Y; Liao YJ; Li XP; Xie D; Peng Y
    Mol Cancer; 2014 Aug; 13():191. PubMed ID: 25128329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
    Huang R; Ke W; Han L; Li J; Liu S; Jiang C
    Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
    Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
    Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin.
    Li J; Zeng H; You Y; Wang R; Tan T; Wang W; Yin L; Zeng Z; Zeng Y; Xie T
    J Nanobiotechnology; 2021 Sep; 19(1):289. PubMed ID: 34565383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.
    Zhao L; Zhu J; Gong J; Song N; Wu S; Qiao W; Yang J; Zhu M; Zhao J
    J Nanobiotechnology; 2020 Oct; 18(1):143. PubMed ID: 33054757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
    Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
    Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo.
    Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
    Kurihara A; Deguchi Y; Pardridge WM
    Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
    Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
    Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
    J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes Combined an Integrin αvβ3-Specific Vector with pH-Responsible Cell-Penetrating Property for Highly Effective Antiglioma Therapy through the Blood-Brain Barrier.
    Shi K; Long Y; Xu C; Wang Y; Qiu Y; Yu Q; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Sep; 7(38):21442-54. PubMed ID: 26371468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.